5.7 million American seniors, or 10 percent of those over age 65, are currently diagnosed with Alzheimer’s disease – and that number is anticipated to rise to as many as 14 million by the year 2050. The race is on as experts scramble to find a cure or, at least, an effective treatment option. And besides the emotional toll the condition takes on both individuals diagnosed and their loved ones, the financial impact is shocking, costing as much as $277 billion in 2018 and expected to grow to over $1 trillion by 2050.


The latest findings in Alzheimer’s clinical trials.

The Alzheimer’s Drug Discovery Foundation has recently introduced its 2017 Alzheimer’s Clinical Trials Report, and the results are very interesting. There are presently 126 types of Alzheimer’s treatment in the clinical stage, specifically to deal with symptom management of these common results of Alzheimer’s:






Sleep Problems

Additionally, researchers are searching further into the underlying causes of the disease, beyond the typical suspected beta-amyloid link. Following are the top types of interventions being tested:

Neuroprotection: A wide range of drugs are exhibiting promising results in preventing neuron damage and boosting neuron survival and regeneration.

Chronic Inflammation: Prior studies have attempted to link inflammation with Alzheimer’s, but the anti-inflammatories tested proved ineffective. Having said that, more recent research includes newer inflammation-targeting drugs, targeted at improving the immune cells and removing toxic proteins.

Genetics: Research that started two years ago in exploring epigenetic treatment therapy is now advancing to add a chemotherapy medication to try to regulate the expression of certain genes.

Repurposed Medications: Less costly and with less testing requirements than new drug development, trials of established medications to test their performance against Alzheimer’s are underway.

Early Intervention: A fresh emphasis has been placed on treating patients who exhibit biological markers indicating an elevated chance of developing the disease, although not yet exhibiting symptoms. Even though these trials may involve invasive medical procedures, such as spinal taps, the ability to prevent or at least slow the progression of Alzheimer’s is really worth considering.

Regency Home Care in Atlanta will continue to monitor clinical trials and any other progress in the journey towards an Alzheimer. For the time being, our agency is also open to provide specialized, compassionate, and highly skilled Alzheimer’s care for seniors. We start by preparing a personalized plan of care to address immediate concerns and then monitor that plan ongoing to ensure the correct level of Alzheimer’s care is always provided as needs change – right within the comfort of home. Call us at (678) 999-2446 or contact us online to learn more about our Marietta home care services or to schedule a free-of-charge in-home assessment.